2017
DOI: 10.3390/ijms18020431
|View full text |Cite
|
Sign up to set email alerts
|

Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector

Abstract: Rotaviruses (RVs) are important enteric pathogens of newborn humans and animals, causing diarrhea and in rare cases death, especially in very young individuals. Rotavirus vaccines presently used are modified live vaccines that lack complete biological safety. Previous work from our laboratory suggested that vaccines based on in situ produced, non-infectious rotavirus-like particles (RVLPs) are efficient while being entirely safe. However, using either vaccine, active mucosal immunization cannot induce protecti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…Moreover, new antenatal vaccines that are designed to potentially control infections driven by major neonatal pathogens, such as group B streptococcus, respiratory syncytial virus and cytomegalovirus, are currently in the developmental phase [ 34 , 35 , 36 , 37 , 38 ] and included in ongoing or completed clinical trials (GBS: [ 39 , 40 ]; RSV: [ 41 ], NCT02247726, NCT02624947; CMV: [ 36 ], NCT00133497). Other vaccines against Rotavirus and Vibrio Cholerae are under investigation for antenatal application [ 42 , 43 ]. More recently, the concern about the harmful results on the fetal brain caused by Zika virus exposure during pregnancy [ 44 , 45 ] triggered the effort to develop a new vaccine for pregnant women, stirring up the debate about the necessity and safety to include pregnant woman in maternal immunization clinical trials [ 45 ].…”
Section: Maternal Immunizationmentioning
confidence: 99%
“…Moreover, new antenatal vaccines that are designed to potentially control infections driven by major neonatal pathogens, such as group B streptococcus, respiratory syncytial virus and cytomegalovirus, are currently in the developmental phase [ 34 , 35 , 36 , 37 , 38 ] and included in ongoing or completed clinical trials (GBS: [ 39 , 40 ]; RSV: [ 41 ], NCT02247726, NCT02624947; CMV: [ 36 ], NCT00133497). Other vaccines against Rotavirus and Vibrio Cholerae are under investigation for antenatal application [ 42 , 43 ]. More recently, the concern about the harmful results on the fetal brain caused by Zika virus exposure during pregnancy [ 44 , 45 ] triggered the effort to develop a new vaccine for pregnant women, stirring up the debate about the necessity and safety to include pregnant woman in maternal immunization clinical trials [ 45 ].…”
Section: Maternal Immunizationmentioning
confidence: 99%
“…CLEM has been used to find rare events by using the fluorescence signal to identify these events and guiding the EM for detailed structural analysis [2,3]. Likewise, CLEM has been used to combine information about specific protein localisations using light microscopy with the contextual information about surrounding cellular membranes and structures using electron microscopy [4][5][6]. This has become even more important in the light of the new diffraction unlimited superresolution techniques which enable the localisation of fluorescent markers with molecular precision, thereby closing the gap between light and electron microscopic resolution.…”
Section: Introductionmentioning
confidence: 99%
“…Resin embedding technique allowed to study several ultrastructural aspects of the intracellular behavior of the TGEV in intestinal fragments of infected pigs [108] and of the parvovirus in intestinal fragments of newborn dogs with diarrhea [220].This technique also allows studying the efficiency of the vaccines based on in situ produced, noninfectious rotavirus-like particles (RVLPs) [221].…”
Section: Resin Embedding Techniquementioning
confidence: 99%